'Porcine Circovirus' vaccine reaches milestone
Ingelvac CircoFLEX from Boehringer Ingelheim has protected more than 2 billion pigs worldwide
Veterinarians and pig farmers were able to protect over two billion pigs around the world against Porcine Circovirus Disease using Ingelvac CircoFLEX vaccine from Boehringer Ingelheim Animal Health. With more than eight pigs vaccinated every second worldwide, the vaccine contributes to sustainable production and supply of healthy, nutritious pork around the world like no other vaccine, according to the company.
“We are very proud of this milestone, and we know that it has been finally achieved by our customers—veterinarians and pig farmers around the world who are doing their best to prevent disease. We would like to thank them for the trust and loyalty they put into Ingelvac CircoFLEX,” said George Heidgerken, Head of Boehringer Ingelheim. “We continue to strive to provide the best protection against Porcine Circovirus to the global pig industry by an integrated solutions approach. This includes the supply of a high-quality vaccine and tailored customer services.”
Porcine Circovirus Disease can have a devastating impact on the pigs’ health, causing suffering to the animals and economic damage to farmers. An infection with the Porcine Circovirus Type 2 (PCV 2) in unprotected pigs may lead to wasting, paleness of the skin, respiratory dysfunction (dyspnea) or diarrhea in piglets. PCV2 can also cause medically and economically relevant subclinical infections (infections without evident clinical signs).
Ingelvac CircoFLEX provides proven protection without compromising safety with just one shot administered around the time of weaning. It is licensed to be freshly mixed with Ingelvac MycoFLEX to protect pigs with one shot against both PCV 2 and Mycoplasma hyopneumoniae, which causes respiratory disease in pigs. Ingelvac CircoFLEX has been recently approved to be used in sows by the European Medicines Agency.